{"topic_id":"ade_bedinvetmab_adverse_events","category":"ade","context":"---\ntopic_id: ade_bedinvetmab_adverse_events\ncategory: ade\ntitle: \"FDA ADE reports for Bedinvetmab (anti-NGF monoclonal antibody (chronic pain / osteoarthritis, dogs & cats)) — total reports, species & reaction breakdown\"\nlang: en\nsource: \"openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-22\"\nsource_file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b8.json\ndate_parsed: 2026-07-22\ntokens_estimated: 194\nverification:\n  method: substring_match\n  claims: 30\n  passed: 30\n  date: 2026-07-22\n---\n\n# Bedinvetmab — FDA Animal & Veterinary Adverse Event (ADE) Reports\n\nSource: openFDA `animalandveterinary/event.json`, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Bedinvetmab is a anti-NGF monoclonal antibody (chronic pain / osteoarthritis, dogs & cats).\n\n## Total reports\nBedinvetmab: 18904\n\n## Reports by species (top entries)\n- Dog 18645\n- Human 130\n- Cat 8\n- Other Canids 4\n\n## Top reported reactions (VEDDRA terms, top entries)\n- Death by euthanasia 2370\n- Lethargy (see also Central nervous system depression in Neurological) 2229\n- Polydipsia 1618\n- Ataxia 1585\n- Seizure NOS 1531\n- Vomiting 1531\n- Polyuria 1515\n- Diarrhoea 1454\n- Urinary incontinence 1358\n- Death 1221\n\n\"Lack of efficacy\" terms denote product-performance reports, not adverse reactions.\n\nSource JSON: `pdf-raw/ade/ade_active_ingredients_2026-07-22_b8.json` (openFDA animalandveterinary/event.json, pulled 2026-07-22).\n","sources":[],"tokens_estimated":273,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}